ArticlePLoS computational biology2026
Semi-parametric empirical bayes method for multiplet detection in snATAC-seq with probabilistic multi-omic integration.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
Abstract
Multiplets arise when multiple cells are captured within the same droplet during single-cell sequencing, producing hybrid molecular profiles that can distort downstream analyses. Detecting multiplets in single-nucleus ATAC-seq (snATAC-seq) data is particularly challenging due to the sparsity and overdispersion of chromatin accessibility measurements. Moreover, computational approaches that jointly leverage evidence across multiple features and data modalities are highly desirable for multiplet detection. We introduce SEBULA, a semi-parametric empirical Bayes framework for multiplet detection in snATAC-seq data. SEBULA models the singlet background directly from observed chromatin accessibility signals using fragment-level information from snATAC-seq data. This approach avoids reliance on synthetic doublets and produces classification probabilities that enable direct false discovery rate control. We further extend SEBULA to integrate complementary evidence from additional features and modalities, such as simultaneously measured gene expression profiles. Across simulations and seven multimodal datasets with hashing-based ground truth, SEBULA demonstrates improved sensitivity and specificity compared with existing snATAC-seq methods. The evidence integration framework achieves comparable or superior performance relative to state-of-the-art multiomic approaches while maintaining computational efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.